Dear Editor, Robotic-assisted bariatric surgery has emerged as a game-changing approach to weight loss therapies, with significant improvements in precision and patient safety above standard laparoscopic procedures. The use of robotic platforms as an adjunct for bariatric surgeries has been connected with a range of outcomes, including operating time, complication rate, and recovery metrics. Research comparing results from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program found that robotic-assisted bariatric surgery has statistically equivalent 30-day patient outcomes as laparoscopic surgery. However, median operating times were much longer in robotic surgery. The decision to use a robotic or laparoscopic method should be based on the surgeon’s experience and prospective expenses1, 2. In revisional bariatric surgery, research has shown that robot-assisted revisions and conversions are just as safe and practical as laparoscopic operations. Nonetheless, the robot-assisted group had a greater average operational duration (155. 5 minutes) than the laparoscopic group (113. 3 minutes). There were no significant differences between the two groups in terms of average duration of stay, 30-day readmission, or 30-day reoperation3. However, nationwide readmissions database research found that robotic-assisted bariatric surgery has a 13% greater risk of complications, a 10% higher risk of readmission, and a 31% higher cost than laparoscopic surgery. These data indicate that, while robotic-assisted surgery provides technical advances, it may also be associated with greater postoperative problems and healthcare costs4. In advanced revisional bariatric surgery, robotic-assisted operations are safe with a low incidence of significant adverse events. Patients who had the treatments experienced satisfactory symptom relief and weight reduction outcomes, demonstrating the effectiveness of the robotic technique in the management of complicated situations5. Robotic bariatric surgery use statistics indicated a 1. 96-fold rise, with sleeve gastrectomy having the greatest growth at 2. 16-fold, followed by Roux-en-Y gastric bypass surgeries increasing 1. 53-fold. Even the 30-day readmission and re-intervention rates fell from 5. 63% to 4. 78% and 2. 31% to 1. 46%, respectively. The overall leak rate fell from 0. 64% to 0. 39%6. Global guidelines for primary robotic bariatric surgery indicate that this technology may improve surgical safety over laparoscopic bariatric surgery. The operational duration is greater with robotic Roux-en-Y gastric bypass, indicating a trade-off between time and safety7. When compared to laparoscopic procedures for revisional Roux-en-Y gastric bypass surgery, robotic surgery resulted in lower postoperative morbidity and shorter hospital stays. This confirms the possibility of using robotic platforms to give care to patients undergoing revisional bariatric surgery8. A systematic analysis found that robotic-assisted bariatric surgery is both safe and viable in highly obese individuals. The review emphasized the benefits of the robotic technique in improving surgical results9. Even AI-based decision-making systems also be used for better outcomes10. Despite the benefits, several studies have found that robotic-assisted revision bariatric operations had longer operational times and increased incidence of certain problems. For example, in gastric bypass patients, robotic surgery had greater rates of aggregate leak and bleeding, whereas laparoscopy had higher transfusion rates. Reoperation, readmission, intervention, sepsis, organ space surgical site infections, and transfusion rates were all higher in sleeve gastrectomy patients who had robotic surgery11. A comprehensive review and meta-analysis of robotic and laparoscopic gastric bypass found no significant differences in main outcome indicators between the two procedures. However, robotic bariatric surgery was associated with a little rise in reoperation rates and no reduction in total complication rates12. Overall, robotic-assisted bariatric surgery has theoretical benefits and drawbacks. It delivers more precision and perhaps better outcomes for some parts of patient care, but it also requires longer operating times and, in some cases, higher costs and complication rates. The decision to adopt a robotic approach should be tailored based on patient-specific considerations, surgeon skill and experience, and resource availability.
Gulothungan et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: